These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24145094)

  • 21. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
    Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
    Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
    Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
    Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
    Molderings GJ; Frölich D; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems.
    Schoeffter P; Bobirnac I; Boddeke E; Hoyer D
    Neuropharmacology; 1997; 36(4-5):429-37. PubMed ID: 9225266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
    Rosenzweig-Lipson S; Zhang J; Mazandarani H; Harrison BL; Sabb A; Sabalski J; Stack G; Welmaker G; Barrett JE; Dunlop J
    Brain Res; 2006 Feb; 1073-1074():240-51. PubMed ID: 16430874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.
    Schechter LE; Lin Q; Smith DL; Zhang G; Shan Q; Platt B; Brandt MR; Dawson LA; Cole D; Bernotas R; Robichaud A; Rosenzweig-Lipson S; Beyer CE
    Neuropsychopharmacology; 2008 May; 33(6):1323-35. PubMed ID: 17625499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
    Pauwels PJ; Palmier C
    Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.
    Borsini F; Bordi F; Poggi A; Di Matteo V
    J Psychopharmacol; 2015 Jul; 29(7):802-11. PubMed ID: 25735994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT
    Chen XF; Jin ZL; Gong Y; Zhao N; Wang XY; Ran YH; Zhang YZ; Zhang LM; Li YF
    Neuropharmacology; 2018 Aug; 138():1-9. PubMed ID: 29805118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz.
    Dalwadi DA; Kim S; Amdani SM; Chen Z; Huang RQ; Schetz JA
    Pharmacol Res; 2016 Aug; 110():10-24. PubMed ID: 27157251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
    Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
    Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
    Contesse V; Hamel C; Lefebvre H; Dumuis A; Vaudry H; Delarue C
    Mol Pharmacol; 1996 Mar; 49(3):481-93. PubMed ID: 8643088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial agonism at serotonin 5-HT1B and dopamine D2L receptors using a luciferase reporter gene assay.
    Kemp DM; George SE; Bungay PJ; Naylor LH
    Eur J Pharmacol; 1999 Jun; 373(2-3):215-22. PubMed ID: 10414442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of 5-HT6 receptors modulates sleep-wake activity and hippocampal theta oscillation.
    Ly S; Pishdari B; Lok LL; Hajos M; Kocsis B
    ACS Chem Neurosci; 2013 Jan; 4(1):191-9. PubMed ID: 23336058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.
    Kiss B; Horváth A; Némethy Z; Schmidt E; Laszlovszky I; Bugovics G; Fazekas K; Hornok K; Orosz S; Gyertyán I; Agai-Csongor E; Domány G; Tihanyi K; Adham N; Szombathelyi Z
    J Pharmacol Exp Ther; 2010 Apr; 333(1):328-40. PubMed ID: 20093397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.